BPC-157, or Body Protection Compound-157, is a synthetic peptide derived from a naturally occurring protein in the stomach. It’s primarily researched for its regenerative and healing properties, especially in tendon, ligament, muscle, and gut repair. BPC-157 is known for promoting angiogenesis (formation of new blood vessels), reducing inflammation, and accelerating tissue recovery.

 

Injectable BPC-157

Form and Administration:

• Typically supplied as a lyophilized (freeze-dried) powder.

• Reconstituted with bacteriostatic water before use.

• Administered subcutaneously (under the skin) or intramuscularly (directly into the tissue near injury).

​

Dosage Protocols: 

• Subcutaneous: 250–500 mcg daily, often split into two injections near the injury site.

• Intramuscular: Similar dosing; more targeted to specific muscles, tendons, or ligaments.

 

Advantages:

• Direct delivery to the bloodstream or local tissue results in higher bioavailability and faster action.

• Often considered more reliable for tissue healing than oral forms.

• Can be targeted near the site of injury for localized repair.

​

Considerations:

• Requires careful preparation and sterile technique.

• Slight discomfort at the injection site.

• Effects are typically reported within days to a couple of weeks, depending on injury severity.

 

Oral BPC-157

Form and Administration:

• Comes as capsules, sublingual tablets, or liquid solutions.

• Taken orally or sublingually, sometimes mixed in water for sublingual absorption.

​

Dosage Protocols:

• Typical doses range from 200–500 mcg per day.

• Sublingual administration may slightly increase bioavailability compared to standard oral ingestion.

​

Advantages:

• Non-invasive and convenient.

• Lower risk of infection or improper administration.

• Suitable for systemic healing, including gut repair, due to its oral bioavailability.

​

Considerations:

• Oral BPC-157 is less studied than injectable forms; absorption can vary.

• Effects may take longer to manifest compared to targeted injections.

• Dosing consistency and gastrointestinal degradation can impact effectiveness.

 

Effects and Benefits (both forms):

• Accelerates healing of tendons, ligaments, muscles, and skin.

• Reduces inflammation and protects tissues from further damage.

• Promotes angiogenesis for faster tissue repair.

• May aid gut lining repair, potentially helping with ulcers or inflammatory gut conditions.

​

Injectable BPC-157

Form: Lyophilized powder reconstituted with bacteriostatic water.

​

Typical Doses:

• Subcutaneous (under the skin): 250–500 mcg per day, often split into 2 injections.

• Intramuscular (into the muscle near injury): 250–500 mcg per day.

• Duration: Usually 2–4 weeks for tissue repair, sometimes longer for chronic injuries.

​

Tips:

• For localized injuries, inject as close as possible to the affected tissue.

• Daily dosing is common; some protocols divide the total daily dose into morning and evening injections.

• Always use sterile technique to prevent infection.

 

Oral BPC-157

Form: Capsules, sublingual tablets, or liquid solutions.

Typical Doses:

• 200–500 mcg per day, sometimes split into 2 doses (morning and evening).

• Sublingual administration may improve absorption.

• Duration mirrors injectable protocols, typically 2–4 weeks for injury repair.

​

Tips:

• Take on an empty stomach to improve absorption.

• Oral is preferred for systemic issues (like gut healing) rather than localized injuries.

 

Combination Protocol (Optional)

Some users combine oral and injectable forms for more comprehensive healing:

• Inject 250 mcg near the injury site daily.

• Take 200–300 mcg orally for systemic support, especially for gut or general tissue repair.

 

Week 1–4: Combined BPC-157 (Subcutaneous/Intramuscular)

• Dose: 250 mcg daily

• Timing: Morning (or split morning/evening: 125 mcg each)

​

Administration:

• Subcutaneous: Inject near the injury site

• Intramuscular: Inject into the muscle closest to the affected tissue.

• Notes: Use sterile technique; rotate injection sites if needed.

• Oral (Capsule or Sublingual)

• Dose: 200–300 mcg daily

• Timing: Morning and evening (split dose 100–150 mcg each)

​

Administration:

• Take on an empty stomach for best absorption.

• Sublingual form may improve bioavailability.

 

​Additional Guidelines

• Duration: 2–4 weeks, depending on injury severity.

• Storage: Keep reconstituted injectable refrigerated; oral forms per label.

• Observation: Monitor healing progress and adjust doses only if necessary.

• Safety: Avoid injections into veins; maintain sterile technique; discontinue if irritation or unusual reactions occur.